AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HIV-1 Transmitted drug resistance and transmission clusters in newly diagnosed patients in Portugal between 2014 and 2019View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Transmitted drug resistance to integrase based first-line treatment in Europe, 2018-2021View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Levels and durability of humoral and T-specific responses after the booster dose of mRNA BNT162b2 vaccine in residents of a Long Term Care FacilityView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodiesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022SARS-CoV-2 mutations and variants may muddle the sensitivity of COVID-19 diagnostic assaysView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencingView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Characterization of SARS-CoV-2 epidemic and transmission dynamics in children over the four COVID-19 wavesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HIV transmission clusters in Europe: A perspective view of Late presenters and Non-Late presentersView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HIV-1 Integrase Resistance Associated Mutations and the Use of Dolutegravir in Sub- Saharan Africa: A Systematic Review and Meta-AnalysisView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Concentration-QTcF modelling and drug-drug interaction of Bedaquiline, Pretomanid and Clofazimine in TB patients.View Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Incidence and determinants of linezolid toxicity in patients with drug-resistant tuberculosis in a high HIV prevalence settingView Abstract
AbstractTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021Simulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapyView Abstract
